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Abstract 
Background: Polyparasitism is a common condition in humans but its impact on the host immune system and 
clinical diseases is still poorly understood. There are few studies of the prevalence and the effect of malaria‑intestinal 
parasite co‑infections in the immune response to malaria vaccine candidates. The present study determines whether 
the presence of malaria and intestinal parasites co‑infection is associated with impaired IgG responses to Plasmodium 
vivax AMA‑1 and MSP‑119 in a rural population of the Brazilian Amazon.
Methods: A cross‑sectional survey was performed in a rural area of Rondonia State and 279 individuals were 
included in the present study. At recruitment, whole blood was collected and Plasmodium and intestinal parasites 
were detected by microscopy and molecular tests. Blood cell count and haemoglobin were also tested and antibody 
response specific to P. vivax AMA‑1 and MSP‑119 was measured in plasma by ELISA. The participants were grouped 
according to their infection status: singly infected with Plasmodium (M); co‑infected with Plasmodium and intestinal 
parasites (CI); singly infected with intestinal parasites (IP) and negative (N) for both malaria and intestinal parasites.
Results: The prevalence of intestinal parasites was significantly higher in individuals with malaria and protozoan 
infections were more prevalent. IgG antibodies to PvAMA‑1 and/or PvMSP‑119 were detected in 74 % of the popula‑
tion. The prevalence of specific IgG was similar for both proteins in all four groups and among the groups the lowest 
prevalence was in IP group. The cytophilic sub‑classes IgG1 and IgG3 were predominant in all groups for PvAMA‑1 
and IgG1, IgG3 and IgG4 for PvMSP‑119. In the case of non‑cytophilic antibodies to PvAMA‑1, IgG2 was significantly 
higher in IP and N group when compared to M and CI while IgG4 was higher in IP group.
Conclusions: The presence of intestinal parasites, mainly protozoans, in malaria co‑infected individuals does not 
seem to alter the antibody immune responses to P. vivax AMA‑1 and MSP‑119. However, IgG response to both AMA1 
and MSP1 were lower in individuals with intestinal parasites.
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Background
It is well known that polyparasitism is a common con-
dition in humans, however, little is known about the 
interaction between parasites and its impact on the host 
immune system and clinical diseases [1]. Malaria and 
intestinal parasitic infections are distributed throughout 
the world and are highly prevalent in humid and warm 
environments in the tropics. The World Health Organi-
zation estimates that 3.3 billion people, almost half the 
world’s population, are at risk of contracting malaria and 
approximately 3.5 billion people are affected by intesti-
nal protozoa and/or helminths [2]. Thus, protozoa of the 
genus Plasmodium, etiological agents of malaria, and 
many species of intestinal parasites (protozoa and hel-
minths) share the same geographic distribution area and 
both types of parasites can infect the same population of 
hosts.
The implication of concomitant infection in humans 
has been evaluated mainly regarding the effects of intesti-
nal helminth infections on falciparum malaria, obtaining 
conflicting results. While Ascaris lumbricoides infection 
may protect against cerebral malaria [3, 4] and Schisto-
soma haematobium has a protective effect on the density 
of the Plasmodium falciparum infection, [5, 6] children 
carrying intestinal helminth infections including Ascaris 
lumbricoides were more susceptive to either P. falcipa-
rum infection or acute malaria attacks [7–9]. In other 
studies, co-infections can make no difference [10–13]. 
In rodent models of co-infection, schistosome and plas-
modia infections are affected at the immunological level 
[14–17]. In humans, studies demonstrating an effect of 
helminths on vaccine-induced immune responses against 
influenza, cholera and tetanus have been described [18, 
19]. So far, little information is available about whether 
and how co-infections of helminths and malaria parasites 
can affect specific immune response to malaria parasites 
and vaccine candidates [20–26]. In some epidemiological 
studies schistosomiasis co-infection favors anti-malarial 
protective antibody responses [21, 25] while in others no 
significant association between schistosome-specific and 
Plasmodium-specific antibody responses was observed 
[22, 23]. Similarly, systemic cytokine levels rose with age 
as well as with infection and exposure to schistosome or 
had no effect [22, 26].
The effects of helminths on falciparum malaria in 
humans remain uncertain and few data are available 
about the interaction between intestinal parasites and 
Plasmodium vivax [27]. In Brazil, P. vivax is the most 
prevalent malaria species corresponding to 83.7 % of the 
134,907 cases registered in 2014 and it is concentrated in 
the Amazon region where intestinal parasites infections 
are prevalent [28, 29].
AMA-1 is expressed on merozoites and sporozoites 
as a type I integral membrane protein and MSP-1 is 
expressed abundantly on the merozoite surface and syn-
thesized as a 195-kDa protein and sequentially processed 
into a cysteine-rich 19-kDa fragment (MSP-119) [30, 31]. 
The proteins MSP-1 and AMA-1 are promising vaccine 
candidates for both P. falciparum and P. vivax and they 
are involved in erythrocyte invasion [32, 33].
Therefore, the aim of the study was to determine the 
prevalence of co-infection of malaria and intestinal 
parasites and whether the presence of co-infection was 
associated with impaired IgG responses against P. vivax 
proteins, apical membrane antigen-1 (AMA-1) and 
merozoite surface protein (MSP-119) in individuals co-
infected with Plasmodium and intestinal parasites and in 
individuals with single infections.
Methods
Study population
The individuals who took part in this study were part of a 
previous study investigating the effect of intestinal para-
sites on the circulating levels of cytokines and inflamma-
tory markers [20]. The study area and population were 
also described in detail in this study. Briefly, a cross-sec-
tional survey was conducted in a rural settlement com-
munity of Porto Velho, municipality of Rondonia State, 
and Brazilian Amazon. Only individuals that lived in the 
area and provided a blood sample and stool samples were 
included in the study (279 participants).
Ethical consideration
Ethical approval was given by the Fundação Oswaldo 
Cruz Ethical Committee (CEP/FIOCRUZ, 492/08). 
Informed and written consents were obtained from all 
participants. For all eligible participants a clinical exami-
nation was performed. Donors positive for P. vivax and/
or P. falciparum at the time of blood collection were 
subsequently treated using the chemotherapeutic regi-
men recommended by the Brazilian Ministry of Health. 
Participants positive for intestinal parasites were also 
treated.
Sample collection and diagnosis
After written informed consent and an epidemiological 
survey from all adult donors or from parents of donors in 
the case of minors, blood samples were collected by veni-
puncture for serological assay and a thick and thin blood 
smear was prepared for microscopic detection of Plasmo-
dium. Parasitaemia was expressed as the number of para-
sites/µL of blood in the thick blood smear. To confirm the 
parasitological diagnoses, molecular analyses of all sam-
ples using primers specific for genus (Plasmodium sp.) 
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and species (P. falciparum and P. vivax) were done. PCR 
amplification and detection and the PCR primers used 
have been previously described [34]. Subjects positive in 
the thick blood smear and/or PCR were considered posi-
tive for malaria infection. Blood cell counts, including 
haematologic indices, were done using an automatic hae-
matology analyzer (Pentra, Horiba Medical, Montpellier, 
France). The individuals were considered anaemic when 
their haemoglobin levels were ≤13 g/dL blood in males 
and ≤12 g/dL blood in females.
Collection and examination of stool samples
For parasitological examinations, participants were 
requested to provide a morning faecal sample and a 
labelled screw-capped plastic container was provided. A 
single stool sample was collected from each subject on 
the following day and samples were screened for intes-
tinal parasites and examined at the same day by direct 
wet mount microscopic and concentration techniques 
by a technician with expertise in intestinal parasites 
identification.
Specific antibody for Plasmodium vivax antigen‑specific 
IgG antibody and sub‑classes in plasma samples
Specific IgG antibodies to PvMSP-119 and PvAMA-1 in 
plasma were determined by enzyme-linked immuno-
sorbent assays (ELISA). The expression and purification 
of the recombinant proteins were performed as previ-
ously described [35, 36]. The recombinant proteins were 
diluted in phosphate-buffered saline (PBS) pH 7.2 to a 
concentration of 2  μg/ml. High-binding ELISA plates 
(Nunc/Maxicorp) were coated with 100 μL of recom-
binant proteins and incubated overnight at 4  °C. Plates 
were washed four times with washing buffer, PBS-0.05 % 
Tween 20 (PBS-T) and were then blocked with block-
ing buffer (PBS-T containing 5  % low-fat milk) for 2  h 
at 37  °C. Individual plasma sample were diluted 1:100 
in blocking buffer, 100 µl were added in duplicate to the 
respective wells and incubated for 1 h at 37 °C. After four 
washes with PBS-T, bound antibodies were detected with 
peroxidase-conjugated goat antihuman IgG (Sigma, St 
Louis, MO, USA) followed by o-phenylenediamine and 
hydrogen peroxide. The absorbance was read at 492 nm 
using an ELISA reader (Spectramax 250, Molecular 
Devices, Sunnyvale, CA, USA). The results for total IgG 
were expressed as reactivity indices (RI), which were cal-
culated by dividing the mean optical density (OD) val-
ues of tested samples by the mean OD values plus three 
standard deviations (SD) of 24 non-exposed control indi-
viduals living in non-endemic areas of malaria (cut-off: 
PvAMA-1  =  0.1881, PvMSP-119  =  0.1915). As positive 
controls, five plasma samples from exposed native indi-
viduals with high antibodies OD levels for both proteins 
were used. Subjects were considered as positive to the 
corresponding antigen if the RI was higher than 1. An 
ELISA to detect the IgG sub-classes was also performed 
for positive responders. Plates were coated with anti-
gen, blocked and incubated with plasma diluted 1:100 
as in the ELISA for total IgG. After washing, plates were 
incubated for 1 h at 22  °C with mouse mAbs to human 
IgG sub-classes diluted in blocking buffer according to 
the manufacturer’s specifications. The mAbs were from 
clones HP-6001 for IgG1, HP-6002 for IgG2, HP-6050 for 
IgG3, and HP-6023 for IgG4 (Sigma) and have been used 
previously to characterize IgG subclass reactivity. After 
incubation, plates were washed and incubated for 1 h at 
22 °C with peroxidase-labelled goat anti-mouse antibody 
(KPL) diluted 1:1,000 in blocking buffer.
Plates were washed, incubated with ABTS (2,2′-Azino-
bis [3-ethylbenzothiazoline-6-sulfonic acid]-diammo-
nium salt) substrate solution, and the (OD) measured as 
described above. Sub-class-specific prevalence for each 
antigen was determined from OD values using three 
standard deviation (SD) above the appropriate mean 
OD of 24 non-exposed controls as the cut-off for 
positivity. The corresponding cut-offs for PvAMA-1 
were: IgG1  =  0.1910, IgG2  =  0.2401, IgG3  =  0.1558, 
IgG4 = 0.1828, and for PvMSP-119 were: IgG1 = 0.1885, 
IgG2 = 0.2718, IgG3 = 0.1579, IgG4 = 0.1462.
Statistical analysis
Epidemiological and experimental data were stored in 
Epi- Info 3.5.1 (CDC, Atlanta, GA, USA). Statistical anal-
ysis were performed using the R statistical environment 
and all p values were adjusted with false discovery rate 
method [37]. The risk of malaria associated with intesti-
nal parasites was estimated using odds ratios (OR) and 
confidence interval of 95  % (CI). Chi-squared (χ2) with 
Yates correction was used to calculate differences in sero-
prevalence between groups. Wilcoxon-Mann–Whitney 
rank sum test was used for comparison between M and 
CI groups. Differences of reactivity index values were cal-
culated with a pairwise test for multiple comparisons of 
mean rank sums (Nemenyi-Tests) [38]. P values of <0.05 
were considered as significant.
Results
Prevalence of malaria and intestinal parasites
Combining the results across all tests (Table 1), 279 indi-
viduals were grouped according to their infection status: 
individuals infected with Plasmodium only (n = 16, M); 
individuals co-infected with Plasmodium and intestinal 
parasites (48, CI); individuals infected with intestinal 
parasites only (98, IP) and individuals negative (117, N). 
The group N was defined as subjects with no symptoms, 
negative for Plasmodium by thick blood smear and PCR 
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and negative for intestinal parasites by direct wet mount 
microscopic and concentration techniques. CI and IP 
groups were composed of individuals positive for intes-
tinal parasite infection: helminths only (H), protozoa only 
(P), and both helminths and protozoa (P+H).
In both M and CI groups, P. vivax was the most preva-
lent species (81.2 and 75.0  %, respectively). The preva-
lence of intestinal parasites was significantly higher in 
individuals infected with malaria (75 %) than with those 
who were not infected (45 %). Of note, all study partici-
pants with malaria presented clinical symptoms, such 
as history of fever and headache, and no difference was 
observed in the parasitaemia levels between malaria and 
co-infected groups. Among the 146 individuals infected 
with intestinal parasites, ten different parasite species 
were detected (Fig. 1), four intestinal protozoa (Giardia 
intestinalis, Entamoeba coli, Entamoeba histolytica, Ioda-
moeba butschlii) and six helminths (Ancylostoma duo-
denale, Strongyloides stercoralis, Ascaris lumbricoides, 
Trichuris trichiura, Hymenolepis nana, Hymenolepis 
diminuta). Giardia intestinalis and Entamoeba coli were 
the most prevalent protozoa, found in single infections or 
associated with other species of protozoa and helminths 
(Ancylostoma duodenale, Strongyloides stercoralis). The 
prevalence of protozoan in CI group (81.25  %) was not 
statistically different from IP (70.4 %). In both, CI and IP 
groups, Giardia intestinalis and Entamoeba coli were the 
most prevalent protozoan and Ancylostoma duodenale, 
Ascaris lumbrocoides the most prevalent helminths.
Characteristics of the studied groups
Table  2 summarizes the characteristics of the studied 
groups. Male were overrepresented in the M and CI 
groups and no differences were observed in the median 
age between all groups. Comparing M and CI groups, 
there were no differences in age, time since last malaria 
episode (LME) and eosinophils count. Anaemia was 
more prevalent in individuals from malaria and co-
infected groups than in IP and N. Additionally, IP and N 
groups were similar and differed from M and CI in LME, 
and both groups presented higher eosinophils counts.
Specific IgG antibody responses to Plasmodium vivax 
AMA‑1 and MSP‑119
The percentage of individuals containing naturally 
acquired IgG antibodies against PvAMA-1 and PvMSP-
119 is presented in Fig.  2. IgG antibodies to PvAMA-1 
and/or PvMSP-119 were detected in 74 % of the popula-
tion. The prevalence of individuals that recognize both 
proteins (55  %) was higher than those that recognize 
a single protein (8  % PvAMA-1 and 11  % PvMSP-119). 
To determine whether the presence of co-infection was 
associated with impaired IgG responses, the prevalence 
of specific IgG directed to PvAMA-1 and PvMSP-119 
between groups were compared (Fig. 3). The prevalence 
of specific IgG was similar for both proteins in all four 
groups and among the groups, the lowest prevalence 
was in IP. The M group presented the highest frequency 
of IgG responders as compared to uninfected, and no 
appreciable differences were observed between M and CI 
groups (Fig.  3a, c). When plasma levels from individual 
serum samples were compared, the RI values obtained 
for the recombinant protein PvAMA-1 were not signifi-
cantly higher than the values obtained for PvMSP-119 
(Fig. 3b, d). However, the RIs were lower in IP group for 
both proteins.
Results in Fig.  4 show the prevalence and reactivity 
index of IgG response specific to PvAMA-1 and PvMSP-1 
in the groups CI and IP among individuals infected with 
helminths (H), protozoa (P) and both protozoa and hel-
minths (PH). There was no significant changes in the 
prevalence and RI of antibody to PvAMA-1 (Fig.  4a) 
and PvMSP-1 (Fig.  4b) in CI and IP groups when indi-
viduals infected with H, P and PH were compared in each 
Table 1 Distribution and  number of  individuals among  the groups and  subgroups according to  malaria and  intestinal 
parasites diagnosis
CI subgroups, H individuals co‑infected with helminths only, P protozoa only, P + H both helminths and protozoa
Groups Subgroups Description Number of individuals Total
Malaria (M) Individuals infected with Plasmodium only 16 16
Co‑infected (CI) H Individuals co‑infected with Plasmodium and helminths only 3
P Individuals co‑infected with Plasmodium and protozoa only 39 48
P+H Individuals co‑infected with Plasmodium and helminths + protozoa 6
Intestinal parasites (IP) H Individuals infected with helminths only 17
P Individuals infected with protozoa only 69 98
P+H Individuals infected with helminths and protozoa only 12
Negative (N) Individuals negative for malaria and intestinal parasites diagnosis 117 117
Total 279
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group. However, IgG response to both PvAMA-1 and 
PvMSP-1 were lower in individuals with protozoa in the 
Intestinal parasites group when compared to Co-infected 
group. Similar results were also observed when the reac-
tivity index were compared between the same groups. 
Although in some groups the sample size were small after 
stratification in H, P and HP, the group of individuals 
with P in both CI and IP groups seemed to be compara-
ble. In the group Intestinal parasites, individuals infected 
with protozoa (P) also presented lower antibodies preva-
lence and RI to PvAMA-1 and PvMSP-1 than the group 
Malaria (p  <  0.001 for PvAMA-1 and Pv-MSP-1) and 
Fig. 1 Prevalence of intestinal parasites among individuals co‑infected with Plasmodium and intestinal parasites (CI) and individuals infected with 
intestinal parasites only (IP) in the studied population. Black bars indicate the frequency of intestinal parasite species in CI group and grey bars 
indicate the frequency of intestinal parasites in the IP group. Y axis illustrates the species corresponding to infections with Protozoa, Helminths and 
Protozoa + Helminths. Numbers on top of bars indicate number of individuals infected with each species of protozoa and helminths
Table 2 Characteristic of the studied groups
All the values in the table represent the median (25–75 %) of the data
Differences between groups were calculated from pairwise test for multiple comparisons of mean rank sums (Nemenyi‑Tests)
Differences of parasitaemia between co‑infected and malaria group were calculated using Wilcoxon, a non‑parametric t test
LME time since last malaria episode
Statistical differences of epidemiological parameters were expressed as * P < 0.05, ** P < 0.001, *** P < 0.0001
a Differences between indicated group and M group
b Differences between indicated group and CI group
Malaria (+)
N = 64
Malaria (−)
N = 215
Malaria (M)a
N = 16
Co‑infected (CI)b
N = 48
Intestinal parasite (IP)c
N = 98
Negative (N)d
N = 117
Gender N (%)
 M 11 (69) 34 (71) 49 (50) 55 (47)
 F 5 (31) 14 (29) 49 (50) 62 (53)
Age (years) 24 (21–33) 31 (22–41) 30 (14–43) 31 (15–39)
Parasitaemia (parasites/µL) 2740 (738.5–56) 1816 (641–57) (–) (–)
LME (months) 6 (0–66) 3 (0–16) 24 (6–60) 10.5 (1–36)
Anemia (%) 56.2 43.7 28a* 23a*b*
Eosinophils (cells/mm3) 73 (36.75–138.75) 104 (42.5–328.5) 328 (185–72)a***b*** 224 (146–44)a**b*
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negative (p < 0.01 for PvAMA-1 and PvMSP-1). In con-
trast, no differences were observed in prevalence and RI 
of antibodies to PvAMA-1 and PvMSP-1 between co-
infected group infected with P and Malaria or Negative 
groups.
Comparison of IgG subclasses to Plasmodium vivax 
PvAMA‑1 and PvMSP‑119
Since the IgG subclass produced in response to a given 
antigen may determine the function of the antibody, 
plasma samples positive for total anti-PvAMA-1 and 
anti-PvMSP-1 IgG were evaluated for IgG sub-class 
responses. Among the IgG responders, the cytophilic 
sub-class IgG1 and IgG3 were predominant in all groups 
for PvAMA-1 and IgG1, IgG3 and IgG4 for PvMSP-119. 
In the case of non-cytophilic antibodies to PvAMA-1, 
IgG2 was significantly higher in IP and N group when 
compared to M and CI, while IgG4 was higher in IP 
group (Fig.  5a, c). No differences were observed in the 
prevalence of non-cytophilic antibodies specific to 
PvMSP-119 among the groups. RIs of specific IgG sub-
classes were also measured and increased IgG1 followed 
by IgG3 were detected for both proteins in all groups 
(Fig. 5b, d). In contrast, although IgG2 and IgG4 were fre-
quent in the groups, their RI was low or similar for both 
proteins in all groups. However, RI of IgG2 to AMA-1 
was significantly higher in IP when compared to CI group 
while IgG4 was higher in IP when compared to N and CI 
groups. Moreover, IgG1 RI to MSP-1 was significantly 
lower in IP group than in N group.
Discussion
Although some studies have explored the influence of 
helminth co-infections on antibody production directed 
to P. falciparum antigens [21, 25, 39, 40], this is the first 
study to evaluate the influence of intestinal parasites 
on the acquired specific humoral immune responses to 
P. vivax malaria antigens [21, 24, 25, 39]. The present 
results show that in malaria-endemic area of Rondonia 
State, the prevalence of individuals singly infected with 
intestinal parasites (52.3 %) and co-infected with malaria 
and intestinal parasites (17.2 %) was higher than that sin-
gly infected with malaria (5.7  %). Some epidemiological 
studies have demonstrated an increased risk of infection 
by P. falciparum in those individuals co-infected with 
helminths but the results were conflicting [3, 6, 27, 40]. 
However, in the present study helminth infection was 
not predominant, the protozoan Giardia intestinalis 
alone or associated with other parasites was the most 
prevalent parasite in IP and CI groups, and P. vivax was 
the predominant Plasmodium species. Studies report-
ing the prevalence of co-infection in malaria-endemic 
areas of Brazil are scarce but a high prevalence of intes-
tinal parasites has been reported in several areas of the 
Brazilian Amazon [27–29]. Although the prevalence of 
intestinal parasites was significantly higher in individu-
als infected with malaria, parasitaemia did not differ 
between co-infected and malaria-infected individuals. 
On the other hand, anaemia was frequent in both groups 
and increased numbers of eosinophils were observed 
in individuals with intestinal parasites and in the unin-
fected group. It seems that the haematological alteration 
observed in both malaria and co-infected groups is due 
to the effect of malaria, rather than intestinal parasites 
or co-infection. Indeed, anaemia is a common feature of 
acute malaria while increased number of eosinophils is 
common in helminths infections [41].
The study of antibody responses to Plasmodium anti-
gens is a key process to the discovery and development 
of malaria vaccines. Several studies report high antibody 
response to P. vivax antigens in individuals exposed to 
malaria infection [42–44]. In malaria-endemic areas of 
Brazil, high prevalences of antibodies specific to P. vivax 
circumsporozoite protein [45], PvMSP-1 [46], MSP-9 
[47], and PvAMA-1 [44] have been reported. In the pre-
sent study, 73.8 % of individuals presented antibodies for 
at least one of the two studied proteins, indicating that 
both proteins are immunogenic. These values are com-
parable to other studies in the Amazon region [44, 46, 
48, 49]. Higher prevalences and RI of specific antibodies 
Fig. 2 Frequency of specific antibody response to PvMSP‑119 and 
PvAMA‑1 of individuals from a malaria‑endemic area, determined by 
ELISA. Individuals were grouped in responders and non‑responders 
for the recombinant proteins. The Y axis represents the frequency 
(%) of individuals responding to PvAMA1+PvMSP‑119, PvAMA‑1 or 
PvMSP‑119 only, and individuals non‑responders to PvAMA‑1 and/or 
PvMSP‑119
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were observed in the groups of individuals with patent 
P. vivax infection (groups M and CI) reaching almost 
100  % in the group of individuals singly infected with 
malaria (M group). This confirms that PvAMA-1 and 
PvMSP-119 are immunogenic molecules during natural 
malaria infections and that the presence of intestinal 
parasites does not interfere in the antibody response 
to both antigens. However, it cannot be ignored the 
reduced IgG prevalence and RI to both proteins in the 
group of individuals singly infected with intestinal para-
sites (IP), even when compared with the Negative Group. 
These results cannot be compared to those that reported 
reduced levels of IgG directed to P. falciparum antigens 
in helminths and P. falciparum co-infection, since hel-
minth infections counted for only 19.7 % of the intestinal 
parasites detected in IP and 29.6 % in CI groups [21, 24]. 
On the other hand, Protozoa were the most prevalent 
intestinal parasites in the IP (70  %) and CI (80  %) and 
reduced antibodies prevalence and reactivity index in 
the IP group could be due to the presence of intestinal 
protozoa. However, in the group CI, the IgG prevalence 
and reactivity indexed were not reduced and were simi-
lar to the group infected with malaria only (M). In the CI 
group, the effect of intestinal protozoa might not be rel-
evant when compared to the effect of Plasmodium in the 
immune response. It seems that Plasmodium have some 
effect on intestinal protozoa and not the contrary since 
lower antibodies response is only observed in IP group. 
Chronic protozoan infections have previously been sug-
gested to be associated with type 1-regulatory immune 
response and combined with the induced pro-inflamma-
tory response induced by the Plasmodium could balance 
the anti-inflammatory effect of the response [50]. Stud-
ies on malaria and protozoan co-infections are rare and 
Fig. 3 Prevalence and reactivity index of IgG antibodies to P. vivax AMA1 and MSP‑119 recombinant antigens. M individuals infected with Plasmo-
dium only, CI individuals co‑infected with Plasmodium and intestinal parasites, IP individuals infected with intestinal parasites only and N negative 
for both malaria and intestinal parasites. a Prevalence of PvAMA‑1 IgG in M, CI, IP and N groups. b IgG Reactivity Index for PvAMA‑1 among M, CI, IP 
and N groups. c Prevalence of PvMSP‑119 IgG in M, CI, IP and N groups. d IgG Reactivity Index for PvMSP‑119 among M, CI, IP and N groups. In b and 
d panels, the horizontal bolded-bar in the Box and whisker plot represents the median value and all individual data points are shown as dots. Whiskers 
extend ×1.5 of the interquartile range or to the minimum/maximum value, when these fall within ×1.5 of the interquartile range. Differences of 
reactivity index values were calculated from pairwise test for multiple comparisons of mean rank sums (Nemenyi‑Tests) and all differences of preva‑
lence between groups were calculated using X2 with Yates correction. Significant statistical differences are represented in the bars and the level of 
significance expressed as *P < 0.05, **P < 0.001, ***P < 0.0001
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the effect of intestinal protozoa on malaria infections or 
the contrary it is unknown.
Analysis of IgG isotypes response to PvAMA-1 and 
PvMSP-119 antigens is important for evaluating pro-
tective activity as IgG subclasses differ in their immune 
effector functions and having such knowledge is impor-
tant for understanding the immunity to vaccine devel-
opment. The results of the present study confirmed 
studies that showed IgG1 and IgG3 isotypes, previously 
identified as protective to malaria, were the predominant 
subclasses in response to both antigens in all groups [44, 
46, 51]. Therefore, the presence of intestinal parasites in 
malaria-infected individuals does not seem to alter the 
cytophilic and non-cytophilic response to PvAMA-1 and 
PvMSP-119 in malaria and intestinal parasites co-infected 
individuals. However, in the IP group IgG1 reactiv-
ity index to MSP-1 were lower when compared to indi-
viduals from N. These results suggest that the presence 
Fig. 4 Prevalence and reactivity index of IgG antibodies to PvAMA‑1 and PvMSP‑119 in the group of individuals co‑infected with malaria and 
intestinal parasites (CI) and infected with intestinal parasites only (IP) according to intestinal parasite infection. H individuals infected with helminths, 
P individuals infected with protozoa, PH individuals infected with protozoa + helminths. a Prevalence of PvAMA‑1 IgG in CI and IP groups among 
H, P and PH infected individuals; b IgG reactivity index for PvAMA‑1 in CI and IP groups among H, P and PH infected individuals; c Prevalence of 
PvMSP‑119 IgG in CI and IP groups among H, P and PH infected individuals; d IgG Reactivity Index for PvMSP‑119 in CI and IP groups among H, P and 
PH infected individuals. In b and d panels, the horizontal bolded-bar in the Box and whisker plot represents the median value and all individual data 
points are shown as dots. Whiskers extend ×1.5 of the interquartile range or to the minimum/maximum value, when these fall within ×1.5 of the 
interquartile range. Differences of reactivity index values were calculated from pairwise test for multiple comparisons of mean rank sums (Nemenyi‑
Tests) and all differences of prevalence between groups were calculated using X2 with Yates correction. Significant statistical differences are repre‑
sented in the bars and the level of significance expressed as *P < 0.05, **P < 0.001, ***P < 0.0001
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of intestinal parasites can induce non-cytophilic anti-
bodies that could counterbalance the production of cyt-
ophilic antibodies in IP group. The increased prevalence 
observed for non-cytophilic IgG2 response to PvAMA-1 
in IP group does not seem to be due to intestinal para-
sites since N group also presented increased IgG2. In 
this group IgG4 RI to AMA-1 were also increased when 
compared to CI and N groups. Studies that investigate 
malaria and helminths co-infection reported a decrease 
of cytophilic IgG1 and IgG3 responses to MSP-1 and an 
increase in non-cytophilic IgG4 response to MSP-3 in 
individuals infected by Ascaris lumbricoides, Strongyloi-
des stercolaris, Trichuris trichiura and Hymenolepis nana 
[52]. Similarly, a generalized decrease in cytophilic IgG 
directed to both GLURP, MSP-3, AMA-1, MSP-1, and 
MSP-2 and a significant negative association between 
Schistosoma infection and IgG1 and IgG3 directed to 
anti-malarial total extract was reported in individuals 
infected with Schistosoma haematobium and malaria 
[24]. In contrast, an increased IgG1 to MSP-1 response 
as well as IgG1 and IgG3 to total extract in malaria 
and Schistosoma haematobium co-infection was also 
reported [21]. Although protozoa infection was predomi-
nant in the present study, it is generally believed that in 
helminth infection the type 2 T helper (Th2) response 
induced by helminths could alter the natural immune 
response of the host to Plasmodium, due to the anti-
inflammatory effect of cytokines induced by helminths. 
However, the cytokine profile of this population have 
been published and for malaria-infected individuals (M 
Fig. 5 Prevalence and reactivity index of IgG subclasses to PvAMA‑1 and PvMSP‑119. M individuals infected with Plasmodium only, CI individu‑
als co‑infected with Plasmodium and intestinal parasites, IP individuals infected with intestinal parasites only and N negative for both malaria and 
intestinal parasites. a Prevalence of IgG subclasses to PvAMA‑119 among groups; b IgG subclasses reactivity index for PvAMA‑1 among; c preva‑
lence of PvMSP‑119 IgG subclasses in M, CI, PI and N groups; d IgG subclasses reactivity index directed for PvMSP‑119 among M, CI, IP and N groups. 
X2 with Yates correction was used to evaluate subclasses differences into the groups. In b and d panels, the horizontal bolded-bar in the Box and 
whisker plot represents the median value and all individual data points are shown as dots. Whiskers extend ×1.5 of the interquartile range or to 
the minimum/maximum value, when these fall within ×1.5 of the interquartile range. Differences of reactivity index values were calculated from 
pairwise test for multiple comparisons of mean rank sums (Nemenyi‑Tests) and all differences of prevalence between groups were calculated using 
X2 with Yates correction. Significant statistical differences are represented in the bars and the level of significance expressed as *P < 0.05, **P < 0.001, 
***P < 0.0001
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and CI groups) the profile showed high levels of IL-1, 
IL-6, TNF, IL-10, and CRP and decreased levels of IL-
17A while for malaria-negative individuals (IP and N) the 
profile was high levels of IL-17A, NO and decreased lev-
els of IL-10 and CRP [20]. Therefore, it seems that intes-
tinal parasites co-infection (mainly protozoan) does not 
influence the plasmatic cytokine levels of acute malaria-
infected individuals.
Conclusions
The presence of antibody responses to both P. vivax AMA-1 
and MSP-1 proteins in all groups indicated that the partici-
pants had been exposed to malaria infection and the IgG 
subclass responses were largely in agreement with pre-
viously published results. Although in the present work 
there were changes in total IgG directed to PvAMA1 and 
PvMSP-119 in Intestinal parasites group, a decrease in IgG 
and in cytophilic responses associated to co-infections was 
not observed. These responses might perhaps relate to other 
factors such as antigen properties, number and time of 
exposure, host age and genetic determinants. Further stud-
ies should be conducted to determine the effect of intestinal 
protozoa in the immune response to malaria antigens.
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